Latest Hikma News & Updates

See the latest news and media coverage for Hikma. We track all announcements, press releases, and industry mentions in real time, all in one place.

Hikma

Global pharmaceutical company

Last updated Today

Latest news about Hikma

May 7 Hikma

Hikma's CEO outlines company's purpose

Said Darwazah emphasizes reliable, affordable medicines across Injectables, Branded, and Hikma Rx segments, highlighting growth, investments, and MENA leadership. Targets $5B revenue by 2030.
May 5 Hikma

Hikma Canada announces partnership with Marius Pharmaceuticals

They enter a commercialisation and distribution agreement for hormone replacement therapy to expand patient access in Canada.
May 1 Hikma

Hikma's legal team argues before US Supreme Court

They advocate for skinny labels to ensure uninterrupted access to safe, affordable generic medicines for American patients.
April 28 Hikma

Hikma announces settlement for VYNDAMAX generic

Hikma settles with Pfizer, allowing market entry on 1 June 2031, ahead of 2035 patent expiry. This supports first-to-file strategy for affordable access.

Yesterday The Globe and Mail

Hikma Advances $250m Share Buyback, Set to Cancel Over 5.3m Shares

An update from Hikma Pharmaceuticals ( (GB:HIK)) is now available. Hikma Pharmaceuticals has continued executing its previously announced $250 million share repurchase programme, buying back...
Yesterday MSN

UK's Hikma Pharma backs outlook on faith in demand, managing Iran war costs

April 23 (Reuters) - Britain's Hikma Pharmaceuticals kept its 2026 outlook unchanged on Thursday and said it was confident it could absorb higher shipping, energy...
May 7 The Globe and Mail

Hikma Confirms Share Capital and Voting Rights for Disclosure Purposes

Detailed price information for Hikma Pharmaceuticals Plc (HKMPF) from The Globe and Mail including charting and trades.
May 6 Drug Store News

Hikma reaches settlement agreement with Pfizer for generic Vyndamax

Hikma has entered into a settlement agreement with Pfizer regarding Hikma's Abbreviated New Drug Application to bring to market a generic version of Vyndamax (tafamidis...

Never miss news about Hikma

Track Hikma and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.

Discover what's making headlines across other trending companies.